AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glypen MF 80 mg/500 mg Tablet

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glypen MF 80 mg/500 mg Tablet

Diabetam Duo 80mg/500mg tablets are classified as antidiabetic agents, a dual-medication formulation for adult type 2 diabetes management. This combination therapy helps regulate blood glucose. Diabetam Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Knowing hypoglycemia symptoms and carrying fast-acting glucose sources (e.g., sugary foods, juice) is vital. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are necessary.

Primary Ingredients of Glypen MF 80 mg/500 mg Tablet

No text provided. Please provide the text you wish to be rephrased.

Uses of Glypen MF 80 mg/500 mg Tablet

Diabetes mellitus type 2

Major Benefits of Glypen MF 80 mg/500 mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 80 mg/500 mg Glypen MF tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glypen MF 80 mg/500 mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glypen MF 80 mg/500 mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80 mg/500 mg Glypen MF tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Glypen MF 80 mg/500 mg Tablet works:

Gliclazide and metformin, combined as Glypen MF 80 mg/500 mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol and Glypen MF 80 mg/500 mg Tablet ingestion is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glypen MF 80 mg/500 mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is mandatory.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glypen MF 80 mg/500 mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glypen MF 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is essential. Glypen MF 80 mg/500 mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glypen MF 80 mg/500 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiating treatment with a reduced Glypen MF 80 mg/500 mg tablet dosage is typical; however, its use is contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Glypen MF 80 mg/500 mg Tablet :

Should you forget a Glypen MF 80 mg/500 mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glypen MF 80 mg/500 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glypen MF 80 mg/500 mg Tablet

Glypen MF 80 mg/500 mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glypen MF 80 mg/500 mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glypen MF 80 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), leading to symptoms like nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Glypen MF 80 mg/500 mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Glypen MF and seek immediate medical attention.
Prolonged use of Glypen MF 80 mg/500 mg tablets can lead to vitamin B12 deficiency by interfering with its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glypen MF 80 mg/500 mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Glypen MF 80 mg/500 mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glypen MF 80 mg/500 mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. Glypen MF is unsuitable for type 1 diabetes.
Glypen MF 80 mg/500 mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glypen MF 80 mg/500 mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry glucose tablets, honey, or fruit juice.
Glypen MF 80 mg/500 mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Glypen MF and seek immediate medical attention.
Prolonged Glypen MF 80 mg/500 mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifested as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glypen MF 80 mg/500 mg Tablets are contraindicated in patients with known allergies to any component or excipient. They should also be avoided in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Glypen MF 80 mg/500 mg tablets is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glypen MF 80 mg/500 mg Ta...
19
MRP 23
17% off